DataVan International Corporation (3521.TWO)
TWD 11.4
(-2.56%)
TWD 11.4
(-2.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 7.67 Million | -372 Thousand | -199.28 Million | 60.44 Million | - |
| Net Income | -188.55 Million | -80.33 Million | -65.6 Million | -41.79 Million | - |
| Depreciation & Amortization | 28.22 Million | 20.96 Million | 18.98 Million | 18.77 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 108.38 Million | 50.13 Million | -151.43 Million | 83.24 Million | - |
| Other non-cash items | 38.01 Million | 17.44 Million | 10.39 Million | 8.5 Million | - |
| Investing Cash Flow | -7.51 Million | -13.29 Million | 1.42 Million | -34.32 Million | - |
| Investments in PPE | -10.2 Million | -10.24 Million | -3.15 Million | -5.26 Million | - |
| Acquisitions | 29 Thousand | - | -20.74 Million | - | 220 Thousand |
| Investment purchases | -222 Thousand | - | - | -45.06 Million | - |
| Sales/Maturities of investments | - | - | - | 4.76 Million | - |
| Other Investing Activities | 2.88 Million | -3.64 Million | 127 Thousand | 11.24 Million | - |
| Financing Cash Flow | 189.54 Million | 22.27 Million | 226.23 Million | -36.21 Million | - |
| Debt repayment | -131.26 Million | -26.56 Million | -229.19 Million | -33.52 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 333.37 Million | - | - | - | - |
| Other Financing Activities | -164 Thousand | -128 Thousand | -106 Thousand | - | - |
| Accounts receivables | 4.68 Million | - | - | - | - |
| Accounts payables | 7.73 Million | - | - | - | - |
| Inventory | 116.33 Million | 49.94 Million | -156.46 Million | 29.41 Million | - |
| Other working capital | -12.62 Million | - | - | - | - |
| Cash at beginning of period | 89.04 Million | 80.35 Million | 52.01 Million | 62.18 Million | - |
| Cash at end of period | 278.73 Million | 89.04 Million | 80.35 Million | 52.01 Million | - |
| Capital Expenditure | -10.2 Million | -10.24 Million | -3.15 Million | -5.26 Million | - |
| Effect of forex changes on cash | -22 Thousand | 92 Thousand | -31 Thousand | -79 Thousand | - |
| Net cash flow / Change in cash | 189.68 Million | 8.69 Million | 28.34 Million | -10.17 Million | - |
| Free Cash Flow | -2.52 Million | -10.62 Million | -202.43 Million | 55.18 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 82.39 Million | -49.07 Million | -188.55 Million | -72.51 Million | -63.86 Million | -9.43 Million |
| Depreciation & Amortization | 2.47 Million | 3.64 Million | 28.22 Million | 5.2 Million | 7.77 Million | 7.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -116.48 Million | 63.12 Million | 108.38 Million | 7.16 Million | 15.2 Million | 49.38 Million |
| Other non-cash items | 2.31 Million | 2.7 Million | 38.01 Million | 750 Thousand | 30.3 Million | 3.37 Million |
| Investing Cash Flow | 134.09 Million | -180.85 Million | -7.51 Million | 1.59 Million | -4.22 Million | -298 Thousand |
| Investments in PPE | 170.18 Million | -172.66 Million | -10.2 Million | -1.89 Million | -3.25 Million | -491 Thousand |
| Acquisitions | 33.99 Million | - | - | - | - | - |
| Investment purchases | -76.82 Million | - | - | - | - | - |
| Sales/Maturities of investments | 178.44 Million | - | - | - | - | - |
| Other Investing Activities | 643 Thousand | -8.2 Million | 2.88 Million | 3.62 Million | -972 Thousand | 245 Thousand |
| Financing Cash Flow | -6.19 Million | -7.08 Million | 189.54 Million | -60.28 Million | 262.87 Million | 9.67 Million |
| Debt repayment | -5.78 Million | -57.01 Million | -131.26 Million | -58.64 Million | -67.36 Million | -13.49 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 333.37 Million | - | - | - |
| Other Financing Activities | -412 Thousand | 50.49 Million | -164 Thousand | - | -27 Thousand | -1000.00 |
| Accounts receivables | 4.09 Million | - | - | - | - | - |
| Accounts payables | -6.35 Million | - | - | - | - | - |
| Inventory | 27.82 Million | 67.86 Million | 116.33 Million | 8.56 Million | 45.6 Million | 53.35 Million |
| Other working capital | -142.67 Million | - | - | - | - | - |
| Cash at beginning of period | 108.8 Million | 278.73 Million | 89.04 Million | 389.16 Million | 117.15 Million | 63.54 Million |
| Cash at end of period | 63.64 Million | 108.8 Million | 278.73 Million | 278.73 Million | 389.16 Million | 117.15 Million |
| Capital Expenditure | 170.18 Million | -172.66 Million | -10.2 Million | -1.89 Million | -3.25 Million | -491 Thousand |
| Effect of forex changes on cash | 2000.00 | 6000.00 | -22 Thousand | -16 Thousand | 35 Thousand | -61 Thousand |
| Net cash flow / Change in cash | -45.15 Million | -169.92 Million | 189.68 Million | -110.43 Million | 272.01 Million | 53.6 Million |
| Free Cash Flow | -2.88 Million | -154.66 Million | -2.52 Million | -53.62 Million | 10.07 Million | 43.8 Million |
GZPZY
CVS
3848
6472
7022
APURE